Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
1/1/1998
1.
Phase I/II Trial of Leuvectin as an Immunotherapeutic Agent by Direct Gene Transfer in Patients With Metastatic Melanoma, Renal Cell Carcinoma, and Sarcoma (Summary Last Modified 01/98)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
18 and over
Pharmaceutical / Industry
MAYO-960106
VCL-1102-102, NCI-G97-1282
Last Modified:
7/1/2002
 
First Published:
4/1/2000
2.
Phase I/II Study of Leuvectin in Patients With Locally Recurrent Organ-Confined Prostate Cancer After Radiotherapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
18 and over
NCI, Pharmaceutical / Industry
UCLA-9906108
VCL-1102-203, NCI-G00-1721, NCT00005072
Last Modified:
7/1/2002
 
First Published:
10/1/1999
3.
Phase II Study of Neoadjuvant Leuvectin Followed by Retropubic Prostatectomy in Patients With Stage II or III Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI, Pharmaceutical / Industry
UCLA-9901077-03B
VCL-1102-202, NCI-G99-1568, NCT00004050
4.
A Trial to Evaluate the Safety of Intratumoral VCL-IM01 Followed by Electroporation in Metastatic Melanoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 and over
Pharmaceutical / Industry
IM01-101
NCT00223899
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute